These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33530494)

  • 1. Compliance to Screening Protocols for Multidrug-Resistant Microorganisms at the Emergency Departments of Two Academic Hospitals in the Dutch-German Cross-Border Region.
    Gunnink LB; Arouri DJ; Jolink FEJ; Lokate M; de Jonge K; Kampmeier S; Kreis C; Raschke M; Kleinjan M; Ter Maaten JC; Friedrich AW; Bathoorn E; Glasner C
    Trop Med Infect Dis; 2021 Jan; 6(1):. PubMed ID: 33530494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicentre screening study on multidrug-resistant organisms in intensive care units in the Dutch-German cross-border region, 2017 to 2018: the importance of healthcare structures.
    Glasner C; Berends MS; Becker K; Esser J; Gieffers J; Jurke A; Kampinga G; Kampmeier S; Klont R; Köck R; von Müller L; Al Naemi N; Ott A; Ruijs G; Saris K; Tami A; Voss A; Waar K; van Zeijl J; Friedrich AW
    Euro Surveill; 2022 Feb; 27(5):. PubMed ID: 35115078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.
    Latour K; Huang TD; Jans B; Berhin C; Bogaerts P; Noel A; Nonhoff C; Dodémont M; Denis O; Ieven M; Loens K; Schoevaerdts D; Catry B; Glupczynski Y
    PLoS One; 2019; 14(3):e0214327. PubMed ID: 30921364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.
    Kajova M; Khawaja T; Kantele A
    J Travel Med; 2022 Jul; 29(4):. PubMed ID: 35234907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
    Bopp TC; Marchesi M; Zihlmann R; Sax H; Wolfensberger A
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1281-1288. PubMed ID: 36912341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.
    Qureshi S; Maria N; Zeeshan M; Irfan S; Qamar FN
    BMC Infect Dis; 2021 Jun; 21(1):547. PubMed ID: 34107903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 - survey results from the RH(E)IN-CARE network.
    Tschudin-Sutter S; Lavigne T; Grundmann H; Rauch J; Eichel VM; Deboscker S; Jaulhac B; Mutters NT
    Swiss Med Wkly; 2021 Mar; 151():w20454. PubMed ID: 33705560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
    Çaǧlayan Ç; Barnes SL; Pineles LL; Harris AD; Klein EY
    Front Public Health; 2022; 10():853757. PubMed ID: 35372195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Survey of Asymptomatic Colonization with Multidrug-Resistant Organisms in a Romanian Tertiary Care Hospital.
    Tălăpan D; Rafila A
    Infect Drug Resist; 2022; 15():2959-2967. PubMed ID: 35706926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms.
    Müller J; Voss A; Köck R; Sinha B; Rossen JW; Kaase M; Mielke M; Daniels-Haardt I; Jurke A; Hendrix R; Kluytmans JA; Kluytmans-van den Bergh MF; Pulz M; Herrmann J; Kern WV; Wendt C; Friedrich AW
    Antimicrob Resist Infect Control; 2015; 4():7. PubMed ID: 25763183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal risk assessment upon hospital admission for screening of carriage with multidrug-resistant micro-organisms in a Dutch tertiary care centre.
    van Hout D; Bruijning-Verhagen PCJ; Blok HEM; Troelstra A; Bonten MJM
    J Hosp Infect; 2021 Mar; 109():32-39. PubMed ID: 33347938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Design of Paired Built Environment Interventions for Control of MDROs in Acute Care and Community Hospitals.
    Squire MM; Sessel GK; Lin G; Squire EN; Igusa T
    HERD; 2021 Apr; 14(2):109-129. PubMed ID: 33375862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
    Maechler F; Peña Diaz LA; Schröder C; Geffers C; Behnke M; Gastmeier P
    Infection; 2015 Apr; 43(2):163-8. PubMed ID: 25395161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
    Birgand G; Mutters NT; Ahmad R; Tacconelli E; Lucet JC; Holmes A;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):33. PubMed ID: 32059746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.
    McKinnell JA; Miller LG; Singh R; Kleinman K; Peterson EM; Evans KD; Dutciuc TD; Heim L; Gombosev A; Estevez M; Launer B; Tjoa T; Tam S; Bolaris MA; Huang SS
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1485-1488. PubMed ID: 27671022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.
    van Dulm E; Tholen ATR; Pettersson A; van Rooijen MS; Willemsen I; Molenaar P; Damen M; Gruteke P; Oostvogel P; Kuijper EJ; Hertogh CMPM; Vandenbroucke-Grauls CMJE; Scholing M
    PLoS One; 2019; 14(9):e0222200. PubMed ID: 31513682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
    Park S; Kim H; Gatchalian KK; Oh H
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.
    Hogardt M; Proba P; Mischler D; Cuny C; Kempf VA; Heudorf U
    Euro Surveill; 2015 Jul; 20(26):. PubMed ID: 26159310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasive MDRO infection in MDRO-colonized patients.
    Alshubaily AM; Alosaimi AS; Alhothli BI; Althawadi SI; Alghamdi SM
    Infect Control Hosp Epidemiol; 2024 Oct; ():1-5. PubMed ID: 39400028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.